HIM
VSTM icon

Hillsdale Investment Management’s Verastem VSTM Stock Holding History

Hillsdale Investment Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,892
Closed -$70K – 538
2017
Q4 		$70K Buy
+1,892
New +$85.4K 0.01% 297

Other funds holding VSTM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Hillsdale Investment Management's VSTM Position: Q1 2018 in Review

Hillsdale Investment Management sold out of Verastem (VSTM) in Q1 2018, closing a stake of 1,892 shares — an estimated $70K sold.

Hillsdale Investment Management first reported a position in VSTM in Q4 2017 and held it in 1 quarter. The position peaked at $70K in Q4 2017. 78 funds tracked by Wall St. Rank hold VSTM as of Q1 2018.

  • Hillsdale Investment Management reported no remaining Verastem position as of Q1 2018 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,892 Verastem shares in Q1 2018, an estimated $70K.
  • Hillsdale Investment Management first reported a position in Verastem in Q4 2017 and held it in 1 quarter.
  • Hillsdale Investment Management's Verastem position peaked at $70K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held Verastem as of Q1 2018.

Based on Hillsdale Investment Management's 13F filing for Q1 2018, filed 14 May 2018.